scholarly article | Q13442814 |
P356 | DOI | 10.1039/C7FO00305F |
P698 | PubMed publication ID | 29147700 |
P50 | author | Yuraporn Sahasakul | Q61797490 |
Anudep Rungsipipat | Q96178532 | ||
Sithichoke Tangphatsornruang | Q56569906 | ||
Pornpimon Angkasekwinai | Q60059410 | ||
P2093 | author name string | Siriporn Tuntipopipat | |
Kemika Praengam | |||
Wuttichai Mhuantong | |||
Piengchai Kupradinun | |||
Kasem Rattanapinyopituk | |||
Khaimuk Changsri | |||
Siriwan Sakarin | |||
Wanwisa Sanitchua | |||
P2860 | cites work | Obesity alters gut microbial ecology | Q24531503 |
Diversity of the human intestinal microbial flora | Q24544241 | ||
Linking long-term dietary patterns with gut microbial enterotypes | Q24609914 | ||
QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
Dysbiosis in inflammatory bowel disease | Q24685931 | ||
Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
The microbiology of butyrate formation in the human colon | Q28217318 | ||
Resistant starches for the management of metabolic diseases | Q28267803 | ||
Resistant starch and energy balance: impact on weight loss and maintenance | Q28307309 | ||
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 | Q28509150 | ||
Oral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice | Q28744643 | ||
Search and clustering orders of magnitude faster than BLAST | Q29547431 | ||
UniFrac: a new phylogenetic method for comparing microbial communities | Q29547435 | ||
UCHIME improves sensitivity and speed of chimera detection | Q29547664 | ||
An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea | Q29617497 | ||
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach | Q29617547 | ||
Ribosomal Database Project: data and tools for high throughput rRNA analysis | Q30703827 | ||
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae | Q33306722 | ||
Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice | Q33412853 | ||
The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. | Q33670800 | ||
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis | Q34369987 | ||
The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases | Q34389606 | ||
Metabolic control of regulatory T cell development and function | Q34790948 | ||
Diversity in gut bacterial community of school-age children in Asia | Q35109207 | ||
A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota | Q35218153 | ||
The gut microbiota of rural papua new guineans: composition, diversity patterns, and ecological processes. | Q35609530 | ||
Adverse symptoms with anti-TNF-alpha therapy in inflammatory bowel disease: systematic review and duration-response meta-analysis | Q35645531 | ||
Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice | Q35747907 | ||
Effect of retrograded rice on weight control, gut function, and lipid concentrations in rats | Q35813001 | ||
Gut microbiota in 2015: Prevotella in the gut: choose carefully | Q35909605 | ||
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease | Q36076691 | ||
Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. | Q36104538 | ||
Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis | Q36330191 | ||
Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation | Q36563545 | ||
Bacteria in the pathogenesis of inflammatory bowel disease. | Q36581339 | ||
Debugging how bacteria manipulate the immune response. | Q36739044 | ||
A review of complementary and alternative approaches to immunomodulation | Q37060108 | ||
Inflammatory bowel disease, past, present and future: lessons from animal models | Q37093634 | ||
Anti-inflammatory activity of bioaccessible fraction from Eryngium foetidum leaves | Q37212245 | ||
Inhibitory effects of resistant starch (RS3) as a carrier for stachyose on dextran sulfate sodium-induced ulcerative colitis in C57BL/6 mice | Q37288680 | ||
Current directions in IBD therapy: what goals are feasible with biological modifiers? | Q37291718 | ||
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer | Q37464715 | ||
The therapeutic impact of manipulating microbiota in inflammatory bowel disease | Q37515945 | ||
Experimental inflammatory bowel disease: insights into the host-microbiota dialog | Q37857437 | ||
Tocotrienols: inflammation and cancer | Q37906700 | ||
Gut inflammation in response to injury: potential target for therapeutic intervention | Q37913399 | ||
Animal models of inflammatory bowel diseases: illuminating the pathogenesis of colitis, ileitis and cancer | Q38053026 | ||
Resistant starch: a promising dietary agent for the prevention/treatment of inflammatory bowel disease and bowel cancer | Q38079440 | ||
Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children | Q38267662 | ||
Positive effects of resistant starch supplementation on bowel function in healthy adults: a systematic review and meta-analysis of randomized controlled trials. | Q38945964 | ||
Rice bran constituents: immunomodulatory and therapeutic activities. | Q39146091 | ||
T cells in inflammatory bowel disease: protective and pathogenic roles | Q40467328 | ||
Chemically induced mouse models of intestinal inflammation | Q42510602 | ||
Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction? | Q42774113 | ||
Slow digestion properties of rice different in resistant starch | Q43115968 | ||
Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons | Q43142955 | ||
Rice bran oil and n-3 fatty acid-rich garden cress (Lepidium sativum) seed oil attenuate murine model of ulcerative colitis | Q43832341 | ||
Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease | Q44400760 | ||
Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis | Q46125639 | ||
Dietary red meat aggravates dextran sulfate sodium-induced colitis in mice whereas resistant starch attenuates inflammation. | Q46962673 | ||
Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats. | Q50429019 | ||
Dietary intervention with green dwarf banana flour (Musa sp AAA) prevents intestinal inflammation in a trinitrobenzenesulfonic acid model of rat colitis. | Q50499787 | ||
Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. | Q51005301 | ||
Can highly purified collagen coating modulate polypropylene mesh immune-inflammatory and fibroblastic reactions? Immunohistochemical analysis in a rat model | Q51105618 | ||
Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? | Q54697654 | ||
P433 | issue | 12 | |
P304 | page(s) | 4630-4643 | |
P577 | publication date | 2017-11-17 | |
P1433 | published in | Food & Function | Q3076426 |
P1476 | title | Brown rice and retrograded brown rice alleviate inflammatory response in dextran sulfate sodium (DSS)-induced colitis mice | |
P478 | volume | 8 |
Q98290847 | Cyclic nigerosylnigerose ameliorates DSS-induced colitis with restoration of goblet cell number and increase in IgA reactivity against gut microbiota in mice |
Q64084240 | Gut Microbiota-Mediated NLRP12 Expression Drives the Attenuation of Dextran Sulphate Sodium-Induced Ulcerative Colitis by Qingchang Wenzhong Decoction |
Q52349005 | The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It. |
Search more.